Metraipolis › archive › dc_7dd62232df4e

Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile — Europe PMC PMID:41277275

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41277275
DOI: 10.1111/joim.70047
License (as archived): solo-consultazione
Archived: 2026-11-08T07:42:35.001Z
SHA-256 of the archived text: cffa0e579cf440084779327ace22daad606ec14662557c50f180e245f1a93aab
Stable URL of this page: https://metraipolis.com/documento/dc_7dd62232df4e

How to cite

Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile — Europe PMC PMID:41277275 — Europe PMC (en), https://europepmc.org/article/MED/41277275 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7dd62232df4e (Metraipolis archive dc_7dd62232df4e, sha256 cffa0e579cf440084779327ace22daad606ec14662557c50f180e245f1a93aab)

BibTeX

@misc{dc7dd62232df4e,
  title = {Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile — Europe PMC PMID:41277275},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41277275},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7dd62232df4e; sha256 cffa0e579cf440084779327ace22daad606ec14662557c50f180e245f1a93aab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41277275. Agents can read the archived copy with the MCP tool read_document.